Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês
Início / Registado na Nigéria / Sulphatriad Tablets

Sulphatriad Tablets

NAFDAC Reg. No. 04-0322 · Drug

Registered with NAFDAC. Registration activeAs of 1 November 2026 · synced automatically from official sources.
Product
Sulphatriad Tablets
Número NAFDAC
04-0322
Princípio ativo
Sulfathiazole; Sulfadiazine; Sulfamerazine
Dosagem
185 mg; 185 mg; 130 mg
Forma
Tablet
Tamanho da embalagem
1 x 500's (in jar)
Manufacturer
Not listed
Applicant (holder)
May & Baker Nigeria PLC
Approved
28 Apr 2026
Situação
Inactive View on NAFDAC ↗
Registro válido até
27 Apr 2031
Alertas da OMS
None found
Community reports
None
Times checked
0

About the medicine: Sulfathiazole: uses, dosage and brands worldwide

What we found

  • Sulphatriad Tablets is on the NAFDAC register with an active registration (04-0322). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Sulphatriad Tablets

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Para quem é

Sulfadiazine Tablets are indicated in the following conditions: Chancroid Trachoma Inclusion conjunctivitis Nocardiosis Urinary tract infections (primarily pyelonephritis, pyelitis and cystitis) in the absence of obstructive uropathy or foreign bodies, when these infections are caused by susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Staphylococcus aureus, Proteus mirabilis and P. vulgaris . Sulfadiazine should be used for urinary tract infections only after use of more soluble sulfonamides has been unsuccessful. …

Como tomar e com que frequência
  • SYSTEMIC SULFONAMIDES ARE CONTRAINDICATED IN INFANTS UNDER 2 MONTHS OF AGE except as adjunctive therapy with pyrimethamine in the treatment of congenital toxoplasmosis
  • Usual Dosage for Infants over 2 Months of Age and Children Initially, one-half the 24-hour dose
  • Maintenance, 150 mg/kg or 4 g/m 2 , divided into 4 to 6 doses, every 24 hours, with a maximum of 6 g every 24 hours
  • Rheumatic fever prophylaxis, under 30 kg (66 pounds), 500 mg every 24 hours; over 30 kg (66 pounds), 1 g every 24 hours
  • Usual Adult Dosage Initially, 2 g to 4 g
  • Maintenance, 2 g to 4 g, divided into 3 to 6 doses, every 24 hours
Talk to a doctor first if
  • Sulfadiazine is contraindicated in the following circumstances: Hypersensitivity to sulfonamides
  • In infants less than 2 months of age (except as adjunctive therapy with pyrimethamine in the treatment of congenital toxoplasmosis)
  • In pregnancy at term and during the nursing period, because sulfonamides cross the placenta and are excreted in breast milk and may cause kernicterus
Warnings

The sulfonamides should not be used for the treatment of group A betahemolytic streptococcal infections. In an established infection, they will not eradicate the streptococcus and, therefore, will not prevent sequelae such as rheumatic fever and glomerulonephritis. Deaths associated with the administration of sulfonamides have been reported from hypersensitivity reactions, agranulocytosis, aplastic anemia and other blood dyscrasias. The presence of such clinical signs as sore throat, fever, pallor, purpura or jaundice may be early indications of serious blood disorders. The frequency of renal complications is considerably lower in patients receiving the more soluble sulfonamides.

Possíveis efeitos colaterais

Blood Dyscrasias Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, purpura, hypoprothrombinemia and methemoglobinemia. Allergic Reactions Erythema multiforme (Stevens-Johnson syndrome), generalized skin eruptions, epidermal necrolysis, urticaria, serum sickness, pruritus, exfoliative dermatitis, anaphylactoid reactions, periorbital edema, conjunctival and scleral injection, photosensitization, arthralgia, allergic myocarditis, drug fever and chills. Gastrointestinal Reactions Nausea, emesis, abdominal pains, hepatitis, diarrhea, anorexia, pancreatitis and stomatitis. C.N.S. …

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-09-24.

Label for sulfathiazole and sulfadiazine and sulfamerazine, the active ingredient registered with NAFDAC.

Check your pack of Sulphatriad Tablets

Add the expiry date on your pack for a full Trust Score.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Fontes oficiais: FDA dos EUA · EMA (UE) · NAFDAC · alertas da OMS

About Sulphatriad Tablets

What is in Sulphatriad Tablets?

Sulphatriad Tablets contains Sulfathiazole; Sulfadiazine; Sulfamerazine (185 mg; 185 mg; 130 mg), as tablet, according to its NAFDAC registration record.

Is Sulphatriad Tablets registered with NAFDAC?

Yes. Sulphatriad Tablets is listed on the NAFDAC register under registration number 04-0322, and its registration is active as of 1 November 2026.

Has Sulphatriad Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Sulphatriad Tablets in our automatically synced alert list.

How can I check that my pack of Sulphatriad Tablets is genuine?

Run a free authenticity scan with the NAFDAC number 04-0322, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Sulphatriad Tablets?

Follow your prescription or the leaflet in your pack. The official label says: SYSTEMIC SULFONAMIDES ARE CONTRAINDICATED IN INFANTS UNDER 2 MONTHS OF AGE except as adjunctive therapy with pyrimethamine in the treatment of congenital toxoplasmosis. Usual Dosage for Infants over 2 Months of Age and Children Initially, one-half the 24-hour dose. Maintenance, 150 mg/kg or 4 g/m 2 , divided into 4 to 6 doses, every 24 hours, with a maximum of 6 g every 24 hour…

What is Sulphatriad Tablets used for?

Sulfadiazine Tablets are indicated in the following conditions: Chancroid Trachoma Inclusion conjunctivitis Nocardiosis Urinary tract infections (primarily pyelonephritis, pyelitis and cystitis) in the absence of obstructive uropathy or foreign bodies, when these infections are caused by susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Sta (Summarised from the official U.S. FDA label for sulfathiazole and sulfadiazine and sulfamerazine. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Sulphatriad Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.